Drug Trial Radar · NCT06372821
A Trial Evaluating the Effect of NIO752 on Tau Synthesis Measured by a Process Known as SILK
Last checked: Nov 19, 2026Latest source record: Jan 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
10
Planned (sponsor's estimate)
Start
Nov 18, 2024
Primary completion
Jul 2026
Study completion Jul 2026
Sponsor
- Lead sponsor
- University College, LondonAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Washington University School of Medicine; University of Washington; Alzheimer's Association; Sigrid Rausing Trust
- First posted
- Apr 18, 2024
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 21 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will assess if drug (NIO752) reduces production of a protein, tau, by the brain. Normally tau maintains the internal skeleton of nerve cells. In Alzheimer's disease (AD) it builds up in the brain, causing damage. Abnormal tau proteins cling to each other forming 'tangles' inside nerve cells, which interfere with how the nerve cells work, and eventually die. This is what causes the symptoms of dementia. It is thought that NIO752 reduces production of tau.
Conditions
- Alzheimer Disease
- Autosomal Dominant Alzheimer Disease Due to Mutation of Presenilin 1 (Disorder)
- Autosomal Dominant Alzheimer Disease Due to Mutation of Presenilin 2 (Disorder)
- Autosomal Dominant Alzheimer Disease Due to Mutation of Amyloid Precursor Protein (Disorder)
Interventions
NIO752Drug
Antisense oligonucleotide
PlaceboOther
Saline
Primary outcomes
What the sponsor says the trial is designed to measure.
- Tau synthesis rate inhibition in individuals with sporadic AD and ADADTime frame: Day 23
Locations
2 sites in 2 countries. Site status is shown where the registry gives one.
Washington University in St. Louis
St Louis, Missouri · Recruiting
University College London Hospitals NHS Foundation Trust
London, United Kingdom · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.